Inflectra vs. Entyvio

Are Entyvio and Inflectra the Same Thing?

Inflectra (infliximab-dyyb) for Injection and Entyvio (vedolizumab) are used to reduce signs and symptoms of Crohn's disease, pediatric Crohn's disease, and ulcerative colitis.

Inflectra is also used to reduce signs and symptoms of rheumatoid arthritis (in combination with methotrexate), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Inflectra and Entyvio belong to different drug classes. Inflectra is a tumor necrosis factor (TNF) blocker and Entyvio is an IgG1 monoclonal antibody.

Side effects of Inflectra and Entyvio that are similar include upper respiratory infections, sinus infections, runny or stuffy nose, bronchitis, sore throat, cough, headache, nausea, rash, itching, fatigue, fever, and joint pain.

Side effects of Inflectra that are different from Entyvio include infusion-related reactions, abdominal pain, indigestion, diarrhea, pain, oral thrush, urinary tract infection (UTI), and high blood pressure (hypertension).

Side effects of Entyvio that are different from Inflectra include common cold symptoms (sinus pain, sneezing), infections of the nose and throat, tiredness, flu symptoms, back pain, and pain in your arms or legs.

Both Inflectra and Entyvio may interact with "live" vaccines.

Inflectra may also interact with anakinra, abatacept, tocilizumab, other biological therapeutics used to treat the same conditions, warfarin, cyclosporine, and theophylline.

Entyvio may also interact with natalizumab and TNF blockers.

SLIDESHOW

Inflammatory Bowel Disease (IBD) Causes, Symptoms, Treatment See Slideshow

What Are Possible Side Effects of Inflectra?

Common side effects of Inflectra include:

  • upper respiratory infections
  • sinus infections
  • runny or stuffy nose
  • sore throat
  • cough
  • bronchitis
  • infusion-related reactions
  • headache
  • abdominal pain
  • nausea
  • diarrhea
  • indigestion
  • rash
  • itching
  • fatigue
  • pain
  • fever
  • oral thrush
  • joint pain
  • urinary tract infection, and
  • high blood pressure (hypertension)

What Are Possible Side Effects of Entyvio?

Common side effects of Entyvio include:

  • common cold symptoms (runny or stuffy nose, sinus pain, sneezing, cough),
  • headache,
  • joint pain,
  • nausea,
  • fever,
  • infections of the nose and throat,
  • tiredness,
  • fatigue,
  • upper respiratory tract infection,
  • bronchitis,
  • flu symptoms,
  • back pain,
  • rash,
  • itching,
  • sinus infection,
  • sore throat, and
  • pain in your arms or legs.

What Is Inflectra?

Inflectra (infliximab-dyyb) for Injection is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of Crohn's disease, pediatric Crohn's disease, ulcerative colitis, rheumatoid arthritis (in combination with methotrexate), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

What Is Entyvio?

Entyvio (vedolizumab) is an IgG1 monoclonal antibody used to treat moderate to severe active ulcerative colitis (UC) and moderate to severe active Crohn's disease (CD).

What Drugs Interact With Inflectra?

Inflectra may interact with anakinra, abatacept, tocilizumab, other biological therapeutics used to treat the same conditions, warfarin, cyclosporine, theophylline, or "live" vaccines. Tell your doctor all medications and supplements you use and all vaccines you recently received. During pregnancy, Inflectra should be administered only if prescribed. It is unknown if it would affect a fetus. It is unknown if Inflectra passes into breast milk. Because of the potential for unwanted effects on a nursing infant, breastfeeding while using Inflectra is not recommended.

What Drugs Interact With Entyvio?

Entyvio may interact with natalizumab, TNF blockers, and "live" vaccines. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Entyvio. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

QUESTION

What is Crohn's disease? See Answer

How Should Inflectra Be Taken?

Inflectra is administered by intravenous infusion and the dose is based on the patient's weight and the condition being treated.

How Should Entyvio Be Taken?

The recommended dosage of Entyvio in adults with ulcerative colitis or Crohn's disease is 300 mg administered by intravenous infusion at zero, two, and six weeks, and then every eight weeks thereafter.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Pfizer. Inflectra Product Information.

https://www.pfizerpro.com/product/inflectra/hcp

Millennium Pharmaceuticals, Inc. Entyvio Product Information.

https://www.entyvio.com

Health Solutions From Our Sponsors